US Edition
Vaccine sales plummet in China, posing a challenge for big pharma: GlobalData - Express Pharma
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Vaccine sales plummet in China, posing a challenge for big pharma: GlobalData - Express Pharma
Multinational pharmaceutical companies (MNCs) are facing significant challenges in China’s vaccine market, as regulatory scrutiny, domestic competition, and changing consumer behaviours disrupt a once-thriving sector. Major players like Merck & Co. and GSK are re-evaluating their strategies in light of these developments, says GlobalData. GlobalData’s Q2 2025 Emerging Market Outsourcing Report reveals that Merck recently reported a 17 per cent d…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
